APP Pharmaceuticals, Inc.
APP Pharmaceuticals
Back to Directory   


 
  News Releases

American Pharmaceutical Partners to Present at The Bear Stearns 18th Annual Healthcare Conference on September 12

- Live Webcast Accessible at www.appdrugs.com -

SCHAUMBURG, Ill., Sept. 6 /PRNewswire-FirstCall/ -- American Pharmaceutical Partners, Inc. (Nasdaq: APPX) today said that the company's senior management will present a company overview at the Bear Stearns 18th Annual Healthcare Conference on Monday, September 12, 2005 at 3:30 p.m. Eastern at the Grand Hyatt Hotel in New York.

The presentation will be available to interested parties through a live webcast at APP's Web site, http://www.appdrugs.com. Listeners are encouraged to visit the Web site at least 15 minutes prior to the beginning of the scheduled presentation to register, download and install any necessary audio software. For those unable to listen to the live webcast, the presentation will be archived on the same Web site for approximately one month.

About American Pharmaceutical Partners

American Pharmaceutical Partners, Inc. is a specialty drug company that develops, manufactures and markets injectable pharmaceutical products, focusing on the oncology, anti-infective and critical care markets. Abraxis Oncology, the proprietary division of APP, is devoted entirely to developing and promoting innovative, next-generation cancer therapies such as ABRAXANE(TM), recently launched for the treatment of metastatic breast cancer. For more information, visit APP's website at http://www.appdrugs.com and http://www.abraxisoncology.com.

Contacts: American Pharmaceutical Partners, Inc.
Nicole Williams
Executive Vice President & CFO
(847) 969-2700

Robert Jaffe/Rob Whetstone
PondelWilkinson Inc.
(310) 279-5963

SOURCE American Pharmaceutical Partners, Inc.
09/06/2005

4463 09/06/2005 07:12 EDT http://www.prnewswire.com